Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuromolecular Medicine|September 20, 2018
The FOXP3 rs3761547 Gene Polymorphism in Multiple Sclerosis as a Male-Specific Risk FactorNatalia Wawrusiewicz-Kurylonek, Monika Chorąży, Renata Posmyk, et al.
Journal of Immunology Research|November 23, 2020
Some Common SNPs of the T-Cell Homeostasis-Related Genes Are Associated with Multiple Sclerosis, but Not with the Clinical Manifestations of the Disease, in the Polish PopulationMonika Chorąży, Natalia Wawrusiewicz-Kurylonek, Edyta Adamska-Patruno, et al.
Multiple Sclerosis and Related Disorders|August 3, 2025
Mortality among patients with multiple sclerosis in PolandKatarzyna Kapica-Topczewska, Olga Zajkowska, Francois Collin, et al.
Frontiers in Neurology|April 23, 2021
Variants of Novel Immunomodulatory Fc Receptor Like 5 Gene Are Associated With Multiple Sclerosis Susceptibility in the Polish PopulationMonika Chorazy, Natalia Wawrusiewicz-Kurylonek, Edyta Adamska-Patruno, et al.
International Journal of Clinical Practice|October 31, 2020
Assessment of anti-HSV antibodies in patients with facial palsy in the course of neuroborreliosisAnna Moniuszko-Malinowska, Katarzyna Guziejko, Agata Czarnowska, et al.
Infectious Diseases (London, England)|September 29, 2015
MRI and planimetric CT follow-up study of patients with severe tick-borne encephalitisPiotr Czupryna, Eugeniusz Tarasow, Anna Moniuszko-Malinowska, et al.
Plos One|May 16, 2025
The impact of serological testing implementation on tick-borne encephalitis detection in PolandJoanna Zajkowska, Elżbieta Waluk, Renata Świerzbińska, et al.
Journal of Clinical Medicine|November 27, 2021
Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in PolandAgata Czarnowska, Katarzyna Kapica-Topczewska, Olga Zajkowska, et al.
Frontiers in Neurology|July 1, 2022
Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in PolandAgata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, et al.
Vaccines|May 28, 2022
Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying TherapiesAgata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, et al.
Pageof 3